PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

HKUST-Beijing Tiantan Hospital researchers discover a new cause for the cerebral cavernous malformation

Laying foundation for non-invasive diagnosis and therapy development

HKUST-Beijing Tiantan Hospital researchers discover a new cause for the cerebral cavernous malformation
2021-06-08
(Press-News.org) Researchers from the Hong Kong University of Science and Technology (HKUST) and Beijing Tiantan Hospital have recently uncovered a new gene mutation responsible for the non-familial patients of cerebral cavernous malformation (CCM) - a brain vascular disorder which inflicted about 10~30 million people in the world.

While the mutation of three genes: namely CCM1, CCM2, and CCM3, were known to be a cause of CCM - they mostly targeted patients who has family history in this disorder - which only account for about 20 per cent of the total inflicted population. The cause for the remaining 80 per cent non-familial cases, however, were not known.

Now, using next-generation sequencing and computational approach, a research team led by Prof. WANG Jiguang, Assistant Professor from HKUST's Division of Life Science and Department of Chemical and Biological Engineering, in collaboration with Prof. CAO Yong from the Beijing Tiantan Hospital, analyzed the genomic data of 113 CCM patients and identified another mutation called MAP3K3 c.1323C>G, which is found to be responsible for almost all the tested cases who developed popcorn-like lesions in their brain arteries - the most common one among the four types of CCM lesions (type II CCM).

At present, magnetic resonance imaging (MRI) is a commonly used non-intrusive means that doctors can base upon for diagnosis and treatment. However, the MRI images can only tell the size and type of the lesions, but not the gene responsible for the problem - which can only be ascertained by surgery and laboratory tests. Now, the HKUST research team designed a computational method that could help assess the probability of connection between the lesion shown in the MRI image to the genetic mutation MAP3K3 c.1323C>G. So CCM patients with this gene mutation may be able to receive more targeted treatment without having to undergo surgery - which could bear serious risks including cerebral hemorrhage or new focal neurological deficits.

Prof. Wang from HKUST said, "Our research opens a new direction to the genetic landscape of CCM and uncovers clues to the correlation between MAP3K3 c.1323C>G gene mutation and type II CCM. The design of the computational method, or decision-tree model takes us a step closer to non-invasive diagnosis of CCM cause, and we hope the discovery could help pave way for candidate drug target and therapy development, bringing benefits to patients in the near future."

The findings were recently published in The American Journal of Human Genetics.

INFORMATION:

Funders: The project Genomics Platform Construction for Chinese Major Brain Disease-AVM, National Key Research and Development Program of China during the 13th Five-Year Plan Period, Clinical Medicine Advanced Discipline Co-construction Project ''Research on the Pathogenesis of Cerebrovascular Diseases'', NSFC Excellent Young Scientists Fund, Hong Kong RGC Fund, Hong Kong ITC Fund, Hong Kong Epigenomics Project, and Department of Science and Technology of Guangdong Province END


[Attachments] See images for this press release:
HKUST-Beijing Tiantan Hospital researchers discover a new cause for the cerebral cavernous malformation

ELSE PRESS RELEASES FROM THIS DATE:

Consumers spent less on candy and desserts when shopping online

2021-06-08
Philadelphia, June 8, 2021 - When shopping online, participants surveyed spent more money, purchased more items, and spent less on candy and desserts than when they shopped in-store, according to a END ...

Orphans and exiles: Research shows the impact of family separation

2021-06-08
BINGHAMTON, N.Y. -- New research from Binghamton University, State University of New York shows the human trauma and family separation that resulted from the Trump Administration's zero tolerance policy on undocumented immigration. The news reports surrounding the Trump Administration's "zero tolerance" policy on undocumented immigration were stark: children separated from their parents, uncertain whether they would ever see them again. All told, the official zero tolerance policy lasted only a few months, from April to June 2018. But family separations occurred before and after those dates: at least 5,512 children were separated from their families since July 2017, and 1,142 families were separated ...

Early endeavors on the path to reliable quantum machine learning

2021-06-08
Anyone who collects mushrooms knows that it is better to keep the poisonous and the non-poisonous ones apart. Not to mention what would happen if someone ate the poisonous ones. In such "classification problems", which require us to distinguish certain objects from one another and to assign the objects we are looking for to certain classes by means of characteristics, computers can already provide useful support to humans. Intelligent machine learning methods can recognise patterns or objects and automatically pick them out of data sets. For example, they could pick out those pictures from a photo database that show non-toxic ...

Super productive 3D bioprinter could help speed up drug development

Super productive 3D bioprinter could help speed up drug development
2021-06-08
A 3D printer that rapidly produces large batches of custom biological tissues could help make drug development faster and less costly. Nanoengineers at the University of California San Diego developed the high-throughput bioprinting technology, which 3D prints with record speed--it can produce a 96-well array of living human tissue samples within 30 minutes. Having the ability to rapidly produce such samples could accelerate high-throughput preclinical drug screening and disease modeling, the researchers said. The process for a pharmaceutical company to develop a new drug can take up to 15 years and cost up to $2.6 billion. It generally begins with screening tens of thousands of drug candidates in ...

In youth, COVID-19 causes more complications than flu; fatality is rate

2021-06-08
NEW YORK, NY--A new global study of 30-day outcomes in children and adolescents with COVID-19 found that while death was uncommon, the illness produced more symptoms and complications than seasonal influenza. The study, "30-day outcomes of Children and Adolescents with COVID-19: An International Experience," published online in the journal Pediatrics, also found significant variation in treatment of children and adolescents hospitalized with COVID-19. Early in the pandemic, opinions around the impact of COVID-19 on children and adolescents ranged from it being no more than the common flu to fear of its potential impact on lesser-developed immune systems. This OHDSI global network study compared the real-world observational data of more ...

Climate change a bigger threat to landscape biodiversity than emerald ash borer

2021-06-07
The emerald ash borer, an invasive beetle native to Southeast Asia, threatens the entire ash tree population in North America and has already changed forested landscapes and caused tens of billions of dollars in lost revenue to the ash sawtimber industry since it arrived in the United States in the 1990s. Despite the devastating impact the beetle has had on forests in the eastern and midwestern parts of the U.S., climate change will have a much larger and widespread impact on these landscapes through the end of the century, according to researchers. "We really wanted to focus on isolating the impact of the emerald ash borer ...

Monoclonal antibody prevents HIV infection in monkeys, study finds

2021-06-07
An experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows. The results will inform a future human clinical trial evaluating leronlimab as a potential pre-exposure prophylaxis, or PrEP, therapy to prevent human infection from the virus that causes AIDS. "Our study findings indicate leronlimab could be a new weapon against the HIV epidemic," said the study's lead researcher and co-corresponding author of this paper, Jonah Sacha, Ph.D., an Oregon Health & Science University professor at OHSU's Oregon National Primate Center and Vaccine & Gene Therapy Institute. "The results of this pre-clinical ...

Toshiba announces breakthrough in long distance quantum communication

Toshiba announces breakthrough in long distance quantum communication
2021-06-07
Cambridge, UK, 7th June 2021: The Cambridge Research Laboratory of Toshiba Europe today announced the first demonstration of quantum communications over optical fibres exceeding 600 km in length. The breakthrough will enable long distance quantum-secured information transfer between metropolitan areas and is a major advance towards building the future Quantum Internet. The term Quantum Internet describes a global network of quantum computers connected by long distance quantum communication links. It is expected to allow the ultrafast solution of complex optimization problems ...

Atom swapping could lead to ultra-bright, flexible next generation LEDs

Atom swapping could lead to ultra-bright, flexible next generation LEDs
2021-06-07
An international group of researchers has developed a new technique that could be used to make more efficient low-cost light-emitting materials which are flexible and can be printed using ink-jet techniques. The researchers, led by the University of Cambridge and the Technical University of Munich, found that by swapping one out of every one thousand atoms of one material for another, they were able to triple the luminescence of a new material class of light emitters known as halide perovskites. This 'atom swapping', or doping, causes the charge ...

A breakthrough in the physics of blood clotting

A breakthrough in the physics of blood clotting
2021-06-07
Heart attacks and strokes -- the leading causes of death in human beings -- are fundamentally blood clots of the heart and brain. Better understanding how the blood-clotting process works and how to accelerate or slow down clotting, depending on the medical need, could save lives. New research by the Georgia Institute of Technology and Emory University published in the journal Biomaterials sheds new light on the mechanics and physics of blood clotting through modeling the dynamics at play during a still poorly understood phase of blood clotting called clot contraction. "Blood clotting is actually a physics-based phenomenon that must occur to stem bleeding after ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] HKUST-Beijing Tiantan Hospital researchers discover a new cause for the cerebral cavernous malformation
Laying foundation for non-invasive diagnosis and therapy development